349501 <common-name>3-[2-[(2-chlorophenyl)methyl]-3h-benzimidazol-5-yl]-1-(4-morpholin-4-ylcyclohexyl)pyrazolo[3,4-d]pyrimidin-4-amine</common-name> <description>3-[2-[(2-chlorophenyl)methyl]-3h-benzimidazol-5-yl]-1-(4-morpholin-4-ylcyclohexyl)pyrazolo[3,4-d]pyrimidin-4-amine is a chemical compound with the formula C29H31ClN8O. With an average molecular weight of 543.10 g/mol, 3-[2-[(2-chlorophenyl)methyl]-3h-benzimidazol-5-yl]-1-(4-morpholin-4-ylcyclohexyl)pyrazolo[3,4-d]pyrimidin-4-amine is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>24180536</pubchem-id> <chemical-formula>C29H31ClN8O</chemical-formula> <weight>543.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T14:07:05Z</created-at> <updated-at type="dateTime">2026-08-31T14:07:05Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CC(CCC1N2CCOCC2)N3C4=NC=NC(=C4C(=N3)C5=CC6=C(C=C5)N=C(N6)CC7=CC=CC=C7Cl)N</moldb-smiles> <moldb-formula>C29H31ClN8O</moldb-formula> <moldb-inchi>InChI=1S/C29H31ClN8O/c30-22-4-2-1-3-18(22)16-25-34-23-10-5-19(15-24(23)35-25)27-26-28(31)32-17-33-29(26)38(36-27)21-8-6-20(7-9-21)37-11-13-39-14-12-37/h1-5,10,15,17,20-21H,6-9,11-14,16H2,(H,34,35)(H2,31,32,33)</moldb-inchi> <moldb-inchikey>DZHMNRMMNFEUNL-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">542.2309353</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM345394</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-[2-[(2-chlorophenyl)methyl]-3h-benzimidazol-5-yl]-1-(4-morpholin-4-ylcyclohexyl)pyrazolo[3,4-d]pyrimidin-4-amine</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Benzimidazoles</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0299825</sync-id> <structure-inchikey>DZHMNRMMNFEUNL-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>d000000001000000000000000000000040000000000000000200010000001000210000020420000000000000008000000000004000000010000000024c0000000000000000000000800000000000000002000000040000000000000000000000004000100000800000020100020040020000000000100000000080000000804000200000000400801000000100000000002000000000001000000004000004000000480000040000020040085000009000000000000000000000080000040080000000000000000010008000020020004200000000000000200000000003000040000000020000000000080000008000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAALQAAAIABBgBgAAAAAgIGAGAAAAAC AgYAYAAAAAMBBgBgAAAAAgIGAGAAAAACAgYAYAAAAAMBBwAgAAAAAwYAYAAA AAICBgBgAAAAAgIIACAAAAACBgBgAAAAAgIGAGAAAAACAgdAKAAAAAMDBkAo AAAAAwQHQCgAAAADAwZAaAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQGQCgAAAAD BAZAKAAAAAMEB0AoAAAAAwMGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEHQCgAAAADAwZAKAAAAAMEB0A4AAAA AwEDBgBgAAAAAgIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMD AQZAaAAAAAMDAQZAKAAAAAMEEQAgAAAAAQcAaAAAAAMBAgsAAQABAgACAwAD BAAEBQAFBgAGBwAHCAAICQAJCgAKCwACDAAMDWgMDQ5oDA4PaAwPEGgMEBFo DBESaAwSE2gMExRoDBMVIBUWaAwWF2gMFxhoDBgZaAwZGmgMGBtoDBscaAwc HWgMHB4AHh8AHyBoDCAhaAwhImgMIiNoDCMkaAwkJQARJiAFAAALBgAUDGgM Eg1oDBoVaAwdF2gMJB9oDEIHAAAABgAFBAMCAQYHCAkKCwYGDg8QERINBRQT Eg0MBhYXGBkaFQUbGBcdHAYgISIjJB8XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:47:36Z</structure-indexed-at> </compound>